APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cognition-Enhancing Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cognition-Enhancing Drugs Industry Growth and Trends Forecast to 2032

22 December 202590 pages

Choose your research edition.

Industry ResearchCognition-Enhancing Drugs Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Cognition-Enhancing Drugs Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Cognition-Enhancing Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cognition-Enhancing Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Cognition-Enhancing Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Cognition-Enhancing Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cognition-Enhancing Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cognition-Enhancing Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cognition-Enhancing Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cognition-Enhancing Drugs include HVMN, Cogstate, Cognition Therapeutics, Biogen Idec and Accelerated Intelligence, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cognition-Enhancing Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cognition-Enhancing Drugs market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cognition-Enhancing Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cognition-Enhancing Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cognition-Enhancing Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cognition-Enhancing Drugs Market by Company

HVMN

Cogstate

Cognition Therapeutics

Biogen Idec

Accelerated Intelligence

Cognition-Enhancing Drugs Segment by Type

Oral

Injection

Cognition-Enhancing Drugs Segment by Application

Retail Pharmacies

Drug Stores

Hospital Pharmacies

Cognition-Enhancing Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cognition-Enhancing Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cognition-Enhancing Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cognition-Enhancing Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cognition-Enhancing Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cognition-Enhancing Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Injection Table 3. Global Cognition-Enhancing Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cognition-Enhancing Drugs Sales by Type (2021-2026) & (k tons) Table 5. Global Cognition-Enhancing Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cognition-Enhancing Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cognition-Enhancing Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Cognition-Enhancing Drugs Price by Type (2021-2026) & (US$/ton) Table 9. Global Cognition-Enhancing Drugs Sales by Type (2027-2032) & (k tons) Table 10. Global Cognition-Enhancing Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cognition-Enhancing Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cognition-Enhancing Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Cognition-Enhancing Drugs Price by Type (2027-2032) & (US$/ton) Table 14. North America Cognition-Enhancing Drugs Sales by Type (2021-2026) & (k tons) Table 15. North America Cognition-Enhancing Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cognition-Enhancing Drugs Sales by Type (2021-2026) & (k tons) Table 17. Europe Cognition-Enhancing Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cognition-Enhancing Drugs Sales by Type (2021-2026) & (k tons) Table 19. Asia-Pacific Cognition-Enhancing Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cognition-Enhancing Drugs Sales by Type (2021-2026) & (k tons) Table 21. Latin America Cognition-Enhancing Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cognition-Enhancing Drugs Sales by Type (2021-2026) & (k tons) Table 23. Middle East and Africa Cognition-Enhancing Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Cognition-Enhancing Drugs Industry Trends Table 25. Cognition-Enhancing Drugs Industry Drivers Table 26. Cognition-Enhancing Drugs Industry Opportunities and Challenges Table 27. Cognition-Enhancing Drugs Industry Restraints Table 28. Global Cognition-Enhancing Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cognition-Enhancing Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Cognition-Enhancing Drugs Sales by Company (2021-2026) & (k tons) Table 31. Global Cognition-Enhancing Drugs Sales Share by Company (2021-2026) Table 32. Global Cognition-Enhancing Drugs Market Price by Company (2021-2026) & (US$/ton) Table 33. Global Cognition-Enhancing Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cognition-Enhancing Drugs Major Company Production Sites and Headquarters Table 35. Global Cognition-Enhancing Drugs Company, Product Type & Application Table 36. Global Cognition-Enhancing Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cognition-Enhancing Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cognition-Enhancing Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cognition-Enhancing Drugs Sales by Region (2021-2026) & (k tons) Table 41. Global Cognition-Enhancing Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cognition-Enhancing Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cognition-Enhancing Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Cognition-Enhancing Drugs Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 45. Global Cognition-Enhancing Drugs Sales by Region (2027-2032) & (k tons) Table 46. Global Cognition-Enhancing Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cognition-Enhancing Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cognition-Enhancing Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Cognition-Enhancing Drugs Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 50. Global Cognition-Enhancing Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cognition-Enhancing Drugs Sales by Application (2021-2026) & (k tons) Table 52. Global Cognition-Enhancing Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cognition-Enhancing Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cognition-Enhancing Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Cognition-Enhancing Drugs Price by Application (2021-2026) & (US$/ton) Table 56. Global Cognition-Enhancing Drugs Sales by Application (2027-2032) & (k tons) Table 57. Global Cognition-Enhancing Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cognition-Enhancing Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cognition-Enhancing Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Cognition-Enhancing Drugs Price by Application (2027-2032) & (US$/ton) Table 61. North America Cognition-Enhancing Drugs Sales by Application (2021-2026) & (k tons) Table 62. North America Cognition-Enhancing Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cognition-Enhancing Drugs Sales by Application (2021-2026) & (k tons) Table 64. Europe Cognition-Enhancing Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cognition-Enhancing Drugs Sales by Application (2021-2026) & (k tons) Table 66. Asia-Pacific Cognition-Enhancing Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cognition-Enhancing Drugs Sales by Application (2021-2026) & (k tons) Table 68. Latin America Cognition-Enhancing Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cognition-Enhancing Drugs Sales by Application (2021-2026) & (k tons) Table 70. Middle East and Africa Cognition-Enhancing Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. HVMN Company Information Table 72. HVMN Business Overview Table 73. HVMN Cognition-Enhancing Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 74. HVMN Cognition-Enhancing Drugs Product Portfolio Table 75. HVMN Recent Development Table 76. Cogstate Company Information Table 77. Cogstate Business Overview Table 78. Cogstate Cognition-Enhancing Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 79. Cogstate Cognition-Enhancing Drugs Product Portfolio Table 80. Cogstate Recent Development Table 81. Cognition Therapeutics Company Information Table 82. Cognition Therapeutics Business Overview Table 83. Cognition Therapeutics Cognition-Enhancing Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 84. Cognition Therapeutics Cognition-Enhancing Drugs Product Portfolio Table 85. Cognition Therapeutics Recent Development Table 86. Biogen Idec Company Information Table 87. Biogen Idec Business Overview Table 88. Biogen Idec Cognition-Enhancing Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 89. Biogen Idec Cognition-Enhancing Drugs Product Portfolio Table 90. Biogen Idec Recent Development Table 91. Accelerated Intelligence Company Information Table 92. Accelerated Intelligence Business Overview Table 93. Accelerated Intelligence Cognition-Enhancing Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 94. Accelerated Intelligence Cognition-Enhancing Drugs Product Portfolio Table 95. Accelerated Intelligence Recent Development Table 96. North America Cognition-Enhancing Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 97. North America Cognition-Enhancing Drugs Sales by Country (2021-2026) & (k tons) Table 98. North America Cognition-Enhancing Drugs Sales Market Share by Country (2021-2026) Table 99. North America Cognition-Enhancing Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 100. North America Cognition-Enhancing Drugs Sales Market Share Forecast by Country (2027-2032) Table 101. North America Cognition-Enhancing Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Cognition-Enhancing Drugs Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Cognition-Enhancing Drugs Market Share by Country (2021-2026) Table 104. North America Cognition-Enhancing Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Cognition-Enhancing Drugs Market Share Forecast by Country (2027-2032) Table 106. Europe Cognition-Enhancing Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 107. Europe Cognition-Enhancing Drugs Sales by Country (2021-2026) & (k tons) Table 108. Europe Cognition-Enhancing Drugs Sales Market Share by Country (2021-2026) Table 109. Europe Cognition-Enhancing Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 110. Europe Cognition-Enhancing Drugs Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Cognition-Enhancing Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Cognition-Enhancing Drugs Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Cognition-Enhancing Drugs Market Share by Country (2021-2026) Table 114. Europe Cognition-Enhancing Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Cognition-Enhancing Drugs Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Cognition-Enhancing Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Cognition-Enhancing Drugs Sales by Country (2021-2026) & (k tons) Table 118. Asia-Pacific Cognition-Enhancing Drugs Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Cognition-Enhancing Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 120. Asia-Pacific Cognition-Enhancing Drugs Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Cognition-Enhancing Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Cognition-Enhancing Drugs Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Cognition-Enhancing Drugs Market Share by Country (2021-2026) Table 124. Asia-Pacific Cognition-Enhancing Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Cognition-Enhancing Drugs Market Share Forecast by Country (2027-2032) Table 126. Latin America Cognition-Enhancing Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 127. Latin America Cognition-Enhancing Drugs Sales by Country (2021-2026) & (k tons) Table 128. Latin America Cognition-Enhancing Drugs Sales Market Share by Country (2021-2026) Table 129. Latin America Cognition-Enhancing Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 130. Latin America Cognition-Enhancing Drugs Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Cognition-Enhancing Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Cognition-Enhancing Drugs Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Cognition-Enhancing Drugs Market Share by Country (2021-2026) Table 134. Latin America Cognition-Enhancing Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Cognition-Enhancing Drugs Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Cognition-Enhancing Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Cognition-Enhancing Drugs Sales by Country (2021-2026) & (k tons) Table 138. Middle East and Africa Cognition-Enhancing Drugs Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Cognition-Enhancing Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 140. Middle East and Africa Cognition-Enhancing Drugs Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Cognition-Enhancing Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Cognition-Enhancing Drugs Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Cognition-Enhancing Drugs Market Share by Country (2021-2026) Table 144. Middle East and Africa Cognition-Enhancing Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Cognition-Enhancing Drugs Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Cognition-Enhancing Drugs Distributors List Table 149. Cognition-Enhancing Drugs Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Cognition-Enhancing Drugs Image Figure 2. Global Cognition-Enhancing Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cognition-Enhancing Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Cognition-Enhancing Drugs Sales (2021-2032) & (k tons) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (k tons) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (k tons) Figure 9. Global Cognition-Enhancing Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cognition-Enhancing Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Cognition-Enhancing Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Cognition-Enhancing Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Cognition-Enhancing Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cognition-Enhancing Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cognition-Enhancing Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cognition-Enhancing Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cognition-Enhancing Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cognition-Enhancing Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cognition-Enhancing Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cognition-Enhancing Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cognition-Enhancing Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Retail Pharmacies Image Figure 24. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k tons) Figure 25. Drug Stores Image Figure 26. Global Drug Stores Sales YoY Growth (2021-2032) & (k tons) Figure 27. Hospital Pharmacies Image Figure 28. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k tons) Figure 29. Global Cognition-Enhancing Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Cognition-Enhancing Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Cognition-Enhancing Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Cognition-Enhancing Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Cognition-Enhancing Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Cognition-Enhancing Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Cognition-Enhancing Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Cognition-Enhancing Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Cognition-Enhancing Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Cognition-Enhancing Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Cognition-Enhancing Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Cognition-Enhancing Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Cognition-Enhancing Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 42. North America Cognition-Enhancing Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Cognition-Enhancing Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Cognition-Enhancing Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Cognition-Enhancing Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 46. Europe Cognition-Enhancing Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cognition-Enhancing Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Cognition-Enhancing Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Cognition-Enhancing Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 50. Asia-Pacific Cognition-Enhancing Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cognition-Enhancing Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Cognition-Enhancing Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Cognition-Enhancing Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 54. Latin America Cognition-Enhancing Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cognition-Enhancing Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Cognition-Enhancing Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Cognition-Enhancing Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 58. Middle East and Africa Cognition-Enhancing Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cognition-Enhancing Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Cognition-Enhancing Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Cognition-Enhancing Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Cognition-Enhancing Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Retail Pharmacies
  • Drug Stores
  • Hospital Pharmacies
Companies covered
  • HVMN
  • Cogstate
  • Cognition Therapeutics
  • Biogen Idec
  • Accelerated Intelligence

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cognition-Enhancing Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cognition-Enhancing Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cognition-Enhancing Drugs Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Injection
  8. 1.4 Global Cognition-Enhancing Drugs Market Size by Type
  9. 1.4.1 Global Cognition-Enhancing Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cognition-Enhancing Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cognition-Enhancing Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cognition-Enhancing Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cognition-Enhancing Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cognition-Enhancing Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cognition-Enhancing Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cognition-Enhancing Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cognition-Enhancing Drugs Industry Trends
  2. 2.2 Cognition-Enhancing Drugs Industry Drivers
  3. 2.3 Cognition-Enhancing Drugs Industry Opportunities and Challenges
  4. 2.4 Cognition-Enhancing Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cognition-Enhancing Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Cognition-Enhancing Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Cognition-Enhancing Drugs Price (2021-2026)
  4. 3.4 Global Cognition-Enhancing Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cognition-Enhancing Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Cognition-Enhancing Drugs Company, Product Type & Application
  7. 3.7 Global Cognition-Enhancing Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cognition-Enhancing Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cognition-Enhancing Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cognition-Enhancing Drugs Tier 1, Tier 2, and Tier 3
4 Cognition-Enhancing Drugs Regional Status and Outlook
  1. 4.1 Global Cognition-Enhancing Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cognition-Enhancing Drugs Historic Market Size by Region
  3. 4.2.1 Global Cognition-Enhancing Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cognition-Enhancing Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cognition-Enhancing Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cognition-Enhancing Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Cognition-Enhancing Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cognition-Enhancing Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cognition-Enhancing Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cognition-Enhancing Drugs by Application
  1. 5.1 Cognition-Enhancing Drugs Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Drug Stores
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Cognition-Enhancing Drugs Market Size by Application
  6. 5.2.1 Global Cognition-Enhancing Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Cognition-Enhancing Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Cognition-Enhancing Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Cognition-Enhancing Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Cognition-Enhancing Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Cognition-Enhancing Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Cognition-Enhancing Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Cognition-Enhancing Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 HVMN
  2. 6.1.1 HVMN Company Information
  3. 6.1.2 HVMN Business Overview
  4. 6.1.3 HVMN Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 HVMN Cognition-Enhancing Drugs Product Portfolio
  6. 6.1.5 HVMN Recent Developments
  7. 6.2 Cogstate
  8. 6.2.1 Cogstate Company Information
  9. 6.2.2 Cogstate Business Overview
  10. 6.2.3 Cogstate Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cogstate Cognition-Enhancing Drugs Product Portfolio
  12. 6.2.5 Cogstate Recent Developments
  13. 6.3 Cognition Therapeutics
  14. 6.3.1 Cognition Therapeutics Company Information
  15. 6.3.2 Cognition Therapeutics Business Overview
  16. 6.3.3 Cognition Therapeutics Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cognition Therapeutics Cognition-Enhancing Drugs Product Portfolio
  18. 6.3.5 Cognition Therapeutics Recent Developments
  19. 6.4 Biogen Idec
  20. 6.4.1 Biogen Idec Company Information
  21. 6.4.2 Biogen Idec Business Overview
  22. 6.4.3 Biogen Idec Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Biogen Idec Cognition-Enhancing Drugs Product Portfolio
  24. 6.4.5 Biogen Idec Recent Developments
  25. 6.5 Accelerated Intelligence
  26. 6.5.1 Accelerated Intelligence Company Information
  27. 6.5.2 Accelerated Intelligence Business Overview
  28. 6.5.3 Accelerated Intelligence Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Accelerated Intelligence Cognition-Enhancing Drugs Product Portfolio
  30. 6.5.5 Accelerated Intelligence Recent Developments
7 North America by Country
  1. 7.1 North America Cognition-Enhancing Drugs Sales by Country
  2. 7.1.1 North America Cognition-Enhancing Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cognition-Enhancing Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Cognition-Enhancing Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cognition-Enhancing Drugs Market Size by Country
  6. 7.2.1 North America Cognition-Enhancing Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cognition-Enhancing Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Cognition-Enhancing Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cognition-Enhancing Drugs Sales by Country
  2. 8.1.1 Europe Cognition-Enhancing Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cognition-Enhancing Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Cognition-Enhancing Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cognition-Enhancing Drugs Market Size by Country
  6. 8.2.1 Europe Cognition-Enhancing Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cognition-Enhancing Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cognition-Enhancing Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cognition-Enhancing Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Cognition-Enhancing Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cognition-Enhancing Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cognition-Enhancing Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cognition-Enhancing Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Cognition-Enhancing Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cognition-Enhancing Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cognition-Enhancing Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cognition-Enhancing Drugs Sales by Country
  2. 10.1.1 South America Cognition-Enhancing Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cognition-Enhancing Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Cognition-Enhancing Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cognition-Enhancing Drugs Market Size by Country
  6. 10.2.1 South America Cognition-Enhancing Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cognition-Enhancing Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Cognition-Enhancing Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cognition-Enhancing Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Cognition-Enhancing Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cognition-Enhancing Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cognition-Enhancing Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cognition-Enhancing Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Cognition-Enhancing Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cognition-Enhancing Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cognition-Enhancing Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cognition-Enhancing Drugs Value Chain Analysis
  2. 12.1.1 Cognition-Enhancing Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cognition-Enhancing Drugs Production Mode & Process
  7. 12.2 Cognition-Enhancing Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cognition-Enhancing Drugs Distributors
  10. 12.2.3 Cognition-Enhancing Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst